130 related articles for article (PubMed ID: 1877399)
1. Regulation of de novo and salvage pathways in chemotherapy.
Weber G; Nagai M; Natsumeda Y; Ichikawa S; Nakamura H; Eble JN; Jayaram HN; Zhen WN; Paulik E; Hoffman R
Adv Enzyme Regul; 1991; 31():45-67. PubMed ID: 1877399
[TBL] [Abstract][Full Text] [Related]
2. Targeted and non-targeted actions of anti-cancer drugs.
Weber G; Prajda N
Adv Enzyme Regul; 1994; 34():71-89. PubMed ID: 7942286
[TBL] [Abstract][Full Text] [Related]
3. Critical issues in chemotherapy with tiazofurin.
Weber G
Adv Enzyme Regul; 1989; 29():75-95. PubMed ID: 2699155
[TBL] [Abstract][Full Text] [Related]
4. Tiazofurin: molecular and clinical action.
Weber G; Prajda N; Abonyi M; Look KY; Tricot G
Anticancer Res; 1996; 16(6A):3313-22. PubMed ID: 9042306
[TBL] [Abstract][Full Text] [Related]
5. Tiazofurin down-regulates expression of c-Ki-ras oncogene in a leukemic patient.
Weber G; Nagai M; Natsumeda Y; Eble JN; Jayaram HN; Paulik E; Zhen WN; Hoffman R; Tricot G
Cancer Commun; 1991 Mar; 3(3):61-6. PubMed ID: 1705812
[TBL] [Abstract][Full Text] [Related]
6. Tiazofurin action in leukemia: evidence for down-regulation of oncogenes and synergism with retinoic acid.
Weber G; Yamaji Y; Nagai M; Natsumeda Y; Jayaram HN; Zhen WN; Paulik E
Adv Enzyme Regul; 1990; 30():35-45. PubMed ID: 2206022
[TBL] [Abstract][Full Text] [Related]
7. Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
Tricot GJ; Jayaram HN; Lapis E; Natsumeda Y; Nichols CR; Kneebone P; Heerema N; Weber G; Hoffman R
Cancer Res; 1989 Jul; 49(13):3696-701. PubMed ID: 2567208
[TBL] [Abstract][Full Text] [Related]
8. Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
Tricot G; Weber G
Anticancer Res; 1996; 16(6A):3341-7. PubMed ID: 9042309
[TBL] [Abstract][Full Text] [Related]
9. Role of differentiation induction in action of purine antimetabolites.
Weber G; Hata Y; Prajda N
Pharm World Sci; 1994 Apr; 16(2):77-83. PubMed ID: 8032345
[TBL] [Abstract][Full Text] [Related]
10. Schedule-dependent synergistic action of tiazofurin and dipyridamole on hepatoma 3924A cells.
Jayaram HN; Murayama K; Pillwein K; Zhen W; Weber G
Cancer Chemother Pharmacol; 1992; 31(2):93-6. PubMed ID: 1451238
[TBL] [Abstract][Full Text] [Related]
11. Sequential impact of tiazofurin and ribavirin on the enzymic program of the bone marrow.
Prajda N; Hata Y; Abonyi M; Singhal RL; Weber G
Cancer Res; 1993 Dec; 53(24):5982-6. PubMed ID: 7903199
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular impact of inhibition of IMP dehydrogenase activity by tiazofurin.
Weber G; Yamaji Y; Olah E; Natsumeda Y; Jayaram HN; Lapis E; Zhen WN; Prajda N; Hoffman R; Tricot GJ
Adv Enzyme Regul; 1989; 28():335-56. PubMed ID: 2576178
[TBL] [Abstract][Full Text] [Related]
13. Salvage capacity of hepatoma 3924A and action of dipyridamole.
Weber G; Lui MS; Natsumeda Y; Faderan MA
Adv Enzyme Regul; 1983; 21():53-69. PubMed ID: 6443595
[TBL] [Abstract][Full Text] [Related]
14. Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemia.
Weber G; Jayaram HN; Lapis E; Natsumeda Y; Yamada Y; Yamaji Y; Tricot GJ; Hoffman R
Adv Enzyme Regul; 1988; 27():405-33. PubMed ID: 2907968
[TBL] [Abstract][Full Text] [Related]
15. Significance of purine salvage in circumventing the action of antimetabolites in rat hepatoma cells.
Natsumeda Y; Ikegami T; Olah E; Weber G
Cancer Res; 1989 Jan; 49(1):88-92. PubMed ID: 2461800
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle dependent regulation of IMP dehydrogenase activity and effect of tiazofurin.
Szekeres T; Fritzer M; Pillwein K; Felzmann T; Chiba P
Life Sci; 1992; 51(16):1309-15. PubMed ID: 1357518
[TBL] [Abstract][Full Text] [Related]
17. Enzymic programs of rat bone marrow and the impact of acivicin and tiazofurin.
Prajda N; Natsumeda Y; Ikegami T; Reardon MA; Szondy S; Hashimoto Y; Emrani J; Weber G
Biochem Pharmacol; 1988 Mar; 37(5):875-80. PubMed ID: 3345200
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the signal transduction program by drugs.
Weber G; Shen F; Prajda N; Yang H; Li W; Yeh A; Csokay B; Olah E; Look KY
Adv Enzyme Regul; 1997; 37():35-55. PubMed ID: 9381980
[TBL] [Abstract][Full Text] [Related]
19. Synergistic action of tiazofurin with hypoxanthine and allopurinol in human neuroectodermal tumor cell lines.
Szekeres T; Schuchter K; Chiba P; Ressmann G; Lhotka C; Gharehbaghi K; Szalay SM; Pillwein K
Biochem Pharmacol; 1993 Dec; 46(11):1903-7. PubMed ID: 7903533
[TBL] [Abstract][Full Text] [Related]
20. Targets and markers of selective action of tiazofurin.
Weber G; Natsumeda Y; Pillwein K
Adv Enzyme Regul; 1985; 24():45-65. PubMed ID: 2424286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
